跳至主要内容
临床试验/NL-OMON47277
NL-OMON47277尚未招募2 期

Multicenter study evaluating the hybrid approach using a novel fluorescence camera - Identifying the value of intraoperative fluorescence imaging during sentinel node biopsy procedures - Evaluating the hybrid approach during sentinel node biopsy

eids Universitair Medisch Centrum0 个研究点目标入组 125 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
125

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Patients >= 18 years;
  • - Patients with a primary or recurrent breast cancer;
  • - Patient with a primary melanoma;
  • - Patients with a primary head-and-neck malignancy;
  • - Patient with a primary or recurrent urological malignancy;
  • - Patients with a primary or recurrent gynecological malignancy;
  • - Patients present with negative regional lymph nodes (exception: vulvar and penile cancer: N1 patients are also eligible);
  • - Patients that will undergo a sentinel node biopsy procedure.

排除标准

  • - History of iodine allergy;
  • - Hyperthyroid or thyroidal adenoma;
  • - Kidney insufficiency;
  • - Pregnant women.

研究者

相似试验